ProPhase Labs, Inc. Deferred Tax Assets, Investments
ProPhase Labs, Inc. (PRPH) had Deferred Tax Assets, Investments of $33.00 thousand as of 2017-12-31, per its 10-K filed 2019-03-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestments · last filed 2019-03-26
- 2017-12-31: Deferred Tax Assets, Investments $33.00K.
- 2016-12-31: Deferred Tax Assets, Investments $938.00K.
- 2015-12-31: Deferred Tax Assets, Investments $1.10M.
- 2014-12-31: Deferred Tax Assets, Investments -$483.00K.
| Period end | Deferred Tax Assets, Investments |
|---|---|
| 2017-12-31 | $33.00K 10-K · filed 2019-03-26 |
| 2016-12-31 | $938.00K 10-K/A · filed 2018-08-20 |
| 2015-12-31 | $1.10M 10-K/A · filed 2018-08-20 |
| 2014-12-31 | -$483.00K 10-K · filed 2017-02-24 |
| 2013-12-31 | -$387.00K 10-K · filed 2016-03-29 |
| 2012-12-31 | $0.00 10-K · filed 2015-03-27 |
| 2011-12-31 | $0.00 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |